Herbas VPB

Print
EN | LT
LT - Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.
EN - Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/00
A61K 38/03
A61K 38/04
A61P 27/02
European patent
(11) Number of the document 2902035
(13) Kind of document T
(96) European patent application number 14004427.2
Date of filing the European patent application 2011-10-14
(97) Date of publication of the European application 2015-08-05
(45) Date of publication and mention of the grant of the patent 2018-06-20
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
PCT/EP2010/0062 2010-10-14 WO
PCT/EP2011/0003 2011-01-25 WO
Inventors
(72)
Combette, Jean-Marc, FR
Deloche, Catherine, CH
Abadie, Claire, FR
Grantee
(73) Xigen Inflammation Ltd., Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY
Title
(54) Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.
  Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.
Last update date 2021-04-30